EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 2,417 shares, a decrease of 52.4% from the July 15th total of 5,079 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 5,465 shares, the short-interest ratio is currently 0.4 days.
EUDA Health Stock Performance
Shares of NASDAQ EUDA traded up $0.32 during mid-day trading on Friday, reaching $14.32. The company had a trading volume of 836 shares, compared to its average volume of 5,688. The company has a 50-day moving average price of $14.93 and a two-hundred day moving average price of $14.63. EUDA Health has a 1-year low of $5.26 and a 1-year high of $86.00.
Institutional Investors Weigh In On EUDA Health
A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC purchased a new stake in EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health as of its most recent filing with the SEC. 4.35% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on EUDA
About EUDA Health
EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.
EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.
Featured Stories
- Five stocks we like better than EUDA Health
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
